These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 18222654)

  • 21. Quantitative evaluation of MPTP-treated nonhuman parkinsonian primates in the HALLWAY task.
    Campos-Romo A; Ojeda-Flores R; Moreno-Briseño P; Fernandez-Ruiz J
    J Neurosci Methods; 2009 Mar; 177(2):361-8. PubMed ID: 19022292
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease.
    Ando R; Choudhury ME; Yamanishi Y; Kyaw WT; Kubo M; Kannou M; Nishikawa N; Tanaka J; Nomoto M; Nagai M
    J Pharmacol Sci; 2018 Apr; 136(4):266-271. PubMed ID: 29661608
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Further characterisation of psychosis-like behaviours induced by L-DOPA in the MPTP-lesioned marmoset.
    Kwan C; Nuara SG; Gourdon JC; Huot P
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Aug; 394(8):1685-1692. PubMed ID: 33963876
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Continuous intraventricular infusion of erythropoietin exerts neuroprotective/rescue effects upon Parkinson's disease model of rats with enhanced neurogenesis.
    Kadota T; Shingo T; Yasuhara T; Tajiri N; Kondo A; Morimoto T; Yuan WJ; Wang F; Baba T; Tokunaga K; Miyoshi Y; Date I
    Brain Res; 2009 Feb; 1254():120-7. PubMed ID: 19101524
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Stepping test in mice: a reliable approach in determining forelimb akinesia in MPTP-induced Parkinsonism.
    Blume SR; Cass DK; Tseng KY
    Exp Neurol; 2009 Sep; 219(1):208-11. PubMed ID: 19460369
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amiloride is neuroprotective in an MPTP model of Parkinson's disease.
    Arias RL; Sung ML; Vasylyev D; Zhang MY; Albinson K; Kubek K; Kagan N; Beyer C; Lin Q; Dwyer JM; Zaleska MM; Bowlby MR; Dunlop J; Monaghan M
    Neurobiol Dis; 2008 Sep; 31(3):334-41. PubMed ID: 18606547
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intraocular microinjections repair experimental Parkinson's disease.
    Willis GL
    Brain Res; 2008 Jun; 1217():119-31. PubMed ID: 18502399
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Damage to the nigrostriatal system in the MPTP-treated SAMP8 mouse.
    Liu J; Wang YY; Liu L; Wang QD; Yuan ZY; Zhang ZX; Gu P; Wang MW
    Neurosci Lett; 2008 Dec; 448(2):184-8. PubMed ID: 18977411
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 6-OHDA-induced hemiparkinsonism and chronic L-DOPA treatment increase dopamine D1-stimulated [(3)H]-GABA release and [(3)H]-cAMP production in substantia nigra pars reticulata of the rat.
    Rangel-Barajas C; Silva I; García-Ramírez M; Sánchez-Lemus E; Floran L; Aceves J; Erlij D; Florán B
    Neuropharmacology; 2008 Oct; 55(5):704-11. PubMed ID: 18588904
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Continuous delivery of ropinirole reverses motor deficits without dyskinesia induction in MPTP-treated common marmosets.
    Stockwell KA; Virley DJ; Perren M; Iravani MM; Jackson MJ; Rose S; Jenner P
    Exp Neurol; 2008 May; 211(1):172-9. PubMed ID: 18321484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nonmotor symptoms in Parkinson's disease: investigating early-phase onset of behavioral dysfunction in the 6-hydroxydopamine-lesioned rat model.
    Branchi I; D'Andrea I; Armida M; Cassano T; Pèzzola A; Potenza RL; Morgese MG; Popoli P; Alleva E
    J Neurosci Res; 2008 Jul; 86(9):2050-61. PubMed ID: 18335518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. D2 receptor stimulation, but not D1, restores striatal equilibrium in a rat model of Parkinsonism.
    Ballion B; Frenois F; Zold CL; Chetrit J; Murer MG; Gonon F
    Neurobiol Dis; 2009 Sep; 35(3):376-84. PubMed ID: 19501163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic inactivation of dopamine D1 but not D2 receptors inhibits L-DOPA-induced dyskinesia and histone activation.
    Darmopil S; Martín AB; De Diego IR; Ares S; Moratalla R
    Biol Psychiatry; 2009 Sep; 66(6):603-13. PubMed ID: 19520364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Comparative study of neurophysiological effects of adamantane derivatives in the experimental parkinsonism model].
    Katunina EA; Samoĭlova EV; Val'dman EA; Nerobkova LN; Voronina TA; Avakian GN
    Eksp Klin Farmakol; 2004; 67(2):16-8. PubMed ID: 15188753
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral treatment with the NADPH oxidase antagonist apocynin mitigates clinical and pathological features of parkinsonism in the MPTP marmoset model.
    Philippens IH; Wubben JA; Finsen B; 't Hart BA
    J Neuroimmune Pharmacol; 2013 Jun; 8(3):715-26. PubMed ID: 23504289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Broad neuroprotective profile of nicotinamide in different mouse models of MPTP-induced parkinsonism.
    Anderson DW; Bradbury KA; Schneider JS
    Eur J Neurosci; 2008 Aug; 28(3):610-7. PubMed ID: 18702732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission.
    Cadoni C; Valentini V; Di Chiara G
    J Neurochem; 2008 Aug; 106(4):1586-93. PubMed ID: 18513369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson's disease models.
    Takeuchi H; Yanagida T; Inden M; Takata K; Kitamura Y; Yamakawa K; Sawada H; Izumi Y; Yamamoto N; Kihara T; Uemura K; Inoue H; Taniguchi T; Akaike A; Takahashi R; Shimohama S
    J Neurosci Res; 2009 Feb; 87(2):576-85. PubMed ID: 18803299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The footfault test as a screening tool in the 6-hydroxydopamine rat model of Parkinson's disease.
    Silvestrin RB; de Oliveira LF; Batassini C; Oliveira A; e Souza TM
    J Neurosci Methods; 2009 Mar; 177(2):317-21. PubMed ID: 19026686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of dopaminergic substances on sleep/wakefulness in saline- and MPTP-treated mice.
    Laloux C; Derambure P; Houdayer E; Jacquesson JM; Bordet R; Destée A; Monaca C
    J Sleep Res; 2008 Mar; 17(1):101-10. PubMed ID: 18275560
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.